Daily News Podcast

FDA approves sufentanil


 

The FDA approves sufentanil for managing pain in patients who are in certified medical health care settings. Also today, Crohn’s disease is tied to anal canal high-risk HPV vaccination. Also today, ultrasound denervation tops radiofrequecy ablation for resistant hypertension, and primary care needs pile up for patients with sickle cell disease.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Screening for intimate partner violence
MDedge Rheumatology
Validation for SLE low-disease definition
MDedge Rheumatology
Heather Yeo: Surgical Residency Attrition
MDedge Rheumatology
AKI linked to later dementia
MDedge Rheumatology
Part B scheme raises concerns
MDedge Rheumatology
Palliative care update highlights role of nonspecialists
MDedge Rheumatology
NSAID risk score validated for CV events
MDedge Rheumatology
TENS improves fibromyalgia pain
MDedge Rheumatology
Is it time to revise ASCVD cardiovascular risk threshold?
MDedge Rheumatology
Samuel Shem: House of God
MDedge Rheumatology